by Hansje P. Smeele,
Eline M.L. Van der Does de Willebois, Yassir Eltahir, Geertruida H. De Bock,
Vera C. Van Aalst, Liesbeth Jansen
The Breast: June 2019, Volume 45, Pages 97-103
Oncoplastic breast
conserving surgery (BCS) frequently induces asymmetry. Contralateral reduction
mammoplasty (CRM) is therefore part of the oncoplastic approach. Our patients
frequently declined CRM when offered as a second-stage procedure after the
completion of adjuvant treatments. This qualitative interview study was
conducted to explore the factors involved in patient decision-making about CRM.
